Try our Advanced Search for more refined results

Expert Analysis

FDA Opens Useful Dialogue On Orange Book Patent Listings

By Jonathan Davies, Jason Lief and Sanya Sukduang (June 18, 2020, 6:48 PM EDT) -- In a notice published in the Federal Register on June 1 concerning the establishment of a public docket via patent information listing in the Orange Book, the U.S. Food and Drug Administration has asked for public comment on the long-standing question as to what types of pharmaceutical patents should be listed in the FDA's Orange Book and "the impact that any change to current patent listing practices may have on drug product development."[1]...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!